Mieke Van Bockstal

Some diffuse large B cell lymphomas (DLBCLs) present with clone-dependent TTF-1 positivity

Mieke Van Bockstal (UGent) , Alessandra Camboni, Elly De Vlieghere (UGent) , Frederic De Ryck (UGent) , Ann-Sophie Candaele, Sofie Geenen (UGent) , Lies Vandemaele (UGent) , Olivier De Wever (UGent) , Louis Libbrecht (UGent) , Sofie Verbeke (UGent) , et al.

(2018) HISTOPATHOLOGY. 72(7). p.1228-1230

Add to list

Comparison of thyroid transcription factor-1 expression by two monoclonal antibodies in schwannomas : the chosen clone matters

David Creytens (UGent) , Mieke Van Bockstal (UGent) , Liesbeth Ferdinande (UGent) and Jo Van Dorpe (UGent)

(2018) HUMAN PATHOLOGY. 76. p.167-168

Add to list

Routine histopathological examination after female-to-male gender-confirming mastectomy

Sofie Van Renterghem, Jo Van Dorpe (UGent) , Stan Monstrey (UGent) , Justine Defreyne (UGent) , Karel Claes (UGent) , Marleen Praet, Sofie Verbeke (UGent) , Guy T'Sjoen (UGent) and Mieke Van Bockstal (UGent)

(2018) BRITISH JOURNAL OF SURGERY. 105(7). p.885-892

Add to list

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits

Mattias Van Heetvelde (UGent) , Mieke Van Bockstal (UGent) , Bruce Poppe (UGent) , Kathleen Lambein, Toon Rosseel (UGent) , Lilit Atanesyan, Dieter Deforce (UGent) , Ivo Van Den Berghe, Kim De Leeneer (UGent) , Jo Van Dorpe (UGent) , et al.

(2018) CANCER LETTERS. 425. p.125-133

Add to list

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast : another causality dilemma?

Mieke Van Bockstal (UGent) , L Libbrecht, G Floris, K Lambein and S Pinder

(2017) ANNALS OF ONCOLOGY. 28(9). p.2317-2317

Add to list

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

Mieke Van Bockstal (UGent) , Giuseppe Floris, Christine Galant, Kathleen Lambein and Louis Libbrecht

(2017) BREAST. 37. p.52-55

Add to list

A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Mieke Van Bockstal (UGent) , Nadine Van Roy (UGent) , Glenn Vergauwen (UGent) , Kathleen Lambein (UGent) , Veronique Cocquyt (UGent) , Louis Libbrecht, Hannelore Denys (UGent) , Marc Bracke (UGent) and Olivier De Wever (UGent)

(2017) BREAST. 32(suppl. 1). p.S48-S48

Add to list

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression

Kathleen Lambein (UGent) , Mieke Van Bockstal (UGent) , Lies Vandemaele (UGent) , Rudy Van den Broecke (UGent) , Veronique Cocquyt (UGent) , Sofie Geenen (UGent) , Hannelore Denys (UGent) and Louis Libbrecht

(2017) VIRCHOWS ARCHIV. 471(5). p.575-587

Add to list

Journal Article
A1
open access

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Lore Lapeire (UGent) , An Hendrix (UGent) , Evelyne Lecoutere, Mieke Van Bockstal (UGent) , Jo Vandesompele (UGent) , Dawn Maynard, Geert Braems (UGent) , Rudy Van den Broecke (UGent) , Cathérine Müller, Marc Bracke (UGent) , et al.

(2017) ONCOTARGET. 8(29). p.47239-47249

Add to list

Second hit landscape in BRCA1/2-associated breast cancer

Mattias Van Heetvelde (UGent) , Mieke Van Bockstal (UGent) , Trees Lepez (UGent) , Kathleen Lambein, Dieter Deforce (UGent) , Anne Vral (UGent) , Bruce Poppe (UGent) , Kim De Leeneer (UGent) , Jo Van Dorpe (UGent) and Kathleen Claes (UGent)

(2017) ANNALS OF ONCOLOGY. 28(suppl. 1).

Academic Bibliography

Mieke Van Bockstal

Some diffuse large B cell lymphomas (DLBCLs) present with clone-dependent TTF-1 positivity

Comparison of thyroid transcription factor-1 expression by two monoclonal antibodies in schwannomas : the chosen clone matters

Routine histopathological examination after female-to-male gender-confirming mastectomy

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast : another causality dilemma?

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Second hit landscape in BRCA1/2-associated breast cancer

Contents

Support

Contact